Kishlay Anand, MD
Clinical Cardiac Electrophysiology · Peoria, AZNPI 1104984491
Payments from drug & device makers
Across 398 payments — averaging $1180.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eli Lilly$407K
- Lexicon Pharmaceuticals, Inc.$20K
- Abbott$15K
- Boston Scientific$14K
- Cvrx, Inc.$7K
- Biosense Webster, Inc.$3K
- plus $5K from 31 others
Across 2 payments — averaging $2013.63 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$4K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eli Lilly | 28 | $406,879 |
| Lexicon Pharmaceuticals, Inc. | 3 | $19,500 |
| Abbott | 106 | $14,830 |
| Boston Scientific | 83 | $14,113 |
| Cvrx, Inc. | 3 | $6,830 |
| Biosense Webster, Inc. | 55 | $2,566 |
| Medtronic(2 entities) | 11 | $1,373 |
| Biotronik Inc. | 20 | $1,265 |
| Medical Device Business Services, Inc. | 3 | $706 |
| Bardy Diagnostics, Inc. | 6 | $205 |
| Canon Medical Systems USA, Inc. | 4 | $200 |
| Novartis | 10 | $194 |
| E.r. Squibb & Sons, L.L.C. | 13 | $146 |
| Tesaro, Inc. | 1 | $125 |
| ZOLL Respicardia, Inc. | 1 | $110 |
| Covidien LP | 1 | $103 |
| Actelion Pharmaceuticals US, Inc. | 4 | $84 |
| Johnson & Johnson | 5 | $82 |
| Pfizer | 5 | $80 |
| Amgen | 5 | $80 |
| Atricure, Inc. | 4 | $80 |
| Siemens Medical Solutions USA, Inc. | 1 | $60 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 4 | $55 |
| Boehringer Ingelheim | 3 | $52 |
| Edwards Lifesciences | 2 | $48 |
| Chiesi USA, Inc. | 3 | $47 |
| United Therapeutics Corporation | 2 | $35 |
| Sanofi-aventis U.S. LLC | 2 | $31 |
| AstraZeneca | 2 | $27 |
| Daiichi Sankyo Inc. | 1 | $23 |
| Astellas Pharma US Inc | 1 | $21 |
| Amarin Pharma, Inc. | 1 | $19 |
| Bayer | 1 | $16 |
| Baylis Medical Company Inc | 1 | $15 |
| Regeneron Healthcare Solutions, Inc. | 1 | $14 |
| Abiomed | 1 | $12 |
| Avinger Inc. | 1 | $11 |
How this compares
$470,035 in reported general payments places this provider in the 90th percentile of 80 clinical cardiac electrophysiology providers in Arizona.
See all clinical cardiac electrophysiology providers in Arizona →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other clinical cardiac electrophysiology in Peoria
- Mark BurnsPeoria$87K
- Amarnauth SinghPeoria$20K
- Vijendra SwarupPhoenix$5.1M
- Akash MakkarPhoenix$3.4M
- Marwan BahuPhoenix$1.7M
- Ashish SadhuScottsdale$1.3M
- Thomas MattioniScottsdale$660K
- Drory TendlerChandler$414K
- Yoaav KrauthammerPhoenix$385K
- Ambrose PanicoMesa$363K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.